Global Lyme Disease Clinical Trials Review, H2, 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Lyme Disease Global Clinical Trials Review, H2, 2016" clinical trials to their offering.

This report provides top line data relating to the clinical trials on Lyme Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Key Topics Covered:

1. Report Guidance
2. Clinical Trials by Region
3. Clinical Trials and Average Enrollment by Country
4. Top Countries Contributing to Clinical Trials in Asia-Pacific
5. Top Five Countries Contributing to Clinical Trials in Europe
6. Top Countries Contributing to Clinical Trials in North America
7. Clinical Trials by G7 Countries: Proportion of Lyme Disease to Infectious Disease Clinical Trials
8. Clinical Trials by Phase in G7 Countries
9. Clinical Trials in G7 Countries by Trial Status
10. Clinical Trials by E7 Countries: Proportion of Lyme Disease to Infectious Disease Clinical Trials
11. Clinical Trials by Phase
12. In Progress Trials by Phase
13. Clinical Trials by Trial Status
14. Clinical Trials by End Point Status
15. Subjects Recruited Over a Period of Time
16. Clinical Trials by Sponsor Type
17. Prominent Sponsors
18. Top Companies Participating in Lyme Disease Therapeutics Clinical Trials
19. Prominent Drugs
20. Clinical Trial Profile Snapshots
21. Appendix

Companies Mentioned

• Baxter International Inc.
• Jubilant Life Sciences Limited
• Valneva SE
• Shire Plc
• Shenzhen Accord Pharmaceutical Co., Ltd.
• LondonPharma Ltd
• Ixodes GmbH
• First Medical Associates
• Appletree AG
• Alkem Laboratories Ltd.

For more information about this clinical trials report visit http://www.researchandmarkets.com/research/tf242w/lyme_disease